BTCY Biotricity, Inc.
Company Analysis
Latest News
🔴 Biotricity is trading 16.67% down today amid Middle East-linked risk aversion
Biotricity is trading at $0.10 (-16.67%) on September 2, 2026, as broader risk aversion linked to Middle East tensions appears to weigh on its thinly traded...
🔴 Biotricity is trading 13.83% down today as U.S. equities weaken
Biotricity is trading 13.83% down now at $0.10 as U.S. equities weaken amid geopolitical tensions, higher oil prices, rising bond yields, and softer labor and...
🔴 Biotricity is trading 8.42% down today as no new catalyst was identified
Biotricity is trading at $0.11, down 8.42%, after no new company-specific catalyst was identified for August 28, 2026. • Volume is 13.59K, below the 87.34K...
🟢 Biotricity is trading 6.76% up today amid broader risk-on market sentiment
Biotricity is trading 6.76% up now at $0.12, appearing most consistent with broader risk appetite, with no clearly identified company-specific catalyst on...
🔴 Biotricity is trading 6.95% down today with no clearly reported company-specific catalyst
Biotricity is trading 6.95% down at $0.11, with no clearly reported company-specific catalyst for August 25, 2026. - On August 18, the company filed a Form...
🟢 Biotricity is trading 7.62% up today with no clear catalyst reported
Biotricity is trading $0.13 (+7.62%) now, with no clearly reported company-specific catalyst for August 24, 2026. - The August 19 Form 10-Q showed higher...
Biotricity revenue climbs to $4.28 million, faces going concern risk
Biotricity, Inc. (BTCY) reported revenue of $4.28 million for the quarter ended June 30, 2026. This figure rose from $3.87 million in the prior-year period....